XML 20 R7.htm IDEA: XBRL DOCUMENT v3.19.1
Condensed Consolidated Statements of Cash Flows - USD ($)
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
OPERATING ACTIVITIES    
Net income $ 1,405,000 $ 117,000
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation 417,000 567,000
Amortization of finite-lived intangible assets 75,000 75,000
(Recovery) impairment of note receivable (4,000) 102,000
Stock-based compensation 64,000 88,000
Deferred income tax expense 46,000 41,000
Loss (gain) on marketable securities 28,000 (21,000)
Dividend from marketable securities   (6,000)
Changes in operating assets and liabilities:    
(Increase) decrease in accounts receivable, net (1,000) 111,000
Increase in inventories, net (591,000) (237,000)
Decrease (increase) in prepaid expenses and other assets 92,000 (28,000)
Increase (decrease) in accounts payable, accrued compensation and commissions expense and other accrued liabilities 125,000 (128,000)
Net cash provided by operating activities 1,656,000 681,000
INVESTING ACTIVITIES    
Purchase of marketable securities   (1,002,000)
Capital expenditures (324,000) (131,000)
Proceeds from sale of land   96,000
Other   34,000
Net cash used in investing activities (324,000) (1,003,000)
FINANCING ACTIVITIES    
(Costs) proceeds from issuance of common stock, net of issuance costs (28,000) 10,794,000
Proceeds from warrant exercise 927,000  
Proceeds from stock option exercise 27,000  
Net cash provided by financing activities 926,000 10,794,000
(Decrease) increase in cash and cash equivalents 2,258,000 10,472,000
Cash and cash equivalents at beginning of year 13,250,000 2,778,000
Cash and cash equivalents at end of year 15,508,000 13,250,000
Supplemental Disclosure:    
Cash paid for interest 23,000 23,000
Cash paid for income taxes $ 69,000 $ 41,000